FDA Clears Point-of-Care Vaginitis PCR Panel with CLIA Waiver
The 20-minute multiplex test delivers eight results covering bacterial vaginosis, Candida species, and trichomoniasis from clinician- or self-collected swabs.
The 20-minute multiplex test delivers eight results covering bacterial vaginosis, Candida species, and trichomoniasis from clinician- or self-collected swabs.
The FDA has cleared Roche’s cobas BV/CV assay, a molecular test that detects bacterial vaginosis and Candida vaginitis from a single swab, enabling streamlined diagnosis on the cobas platform, according to Roche.
Utepreva LLC has received FDA clearance for its single-use endometrial sampler, which employs three sampling mechanisms to improve tissue yield for cytologic and molecular analysis in early endometrial cancer detection.
A peer-reviewed study in the Journal of Minimally Invasive Gynecology found HerAnova’s HerResolve blood assay detected 61.5% of endometriosis cases missed by imaging, with 97.5% specificity and 80% sensitivity.
Read MoreHerAnova Lifesciences has launched HerResolve, the first blood-based test for endometriosis detection, at IVF centers nationwide. Validation studies show diagnostic accuracy comparable to surgical standards, according to the company.
Read MorePD-L1 testing is now cleared to help identify patients with epithelial ovarian, fallopian tube, or primary peritoneal carcinoma who may be eligible for anti–PD-1 therapy.
Read MoreThe company will process clinical samples for Path Fertility’s NOA Guide, an epigenetic test designed to inform surgical decision-making for men with non-obstructive azoospermia.
Read MoreBillionToOne has partnered with Epic to integrate its UNITY Complete prenatal and Northstar oncology tests into Epic’s EHR system, enabling direct ordering and results delivery for healthcare providers.
Read MoreSpecial issue explores advances in noninvasive prenatal screening, molecular diagnostics, and care disparities affecting perinatal outcomes.
Read MoreStudy finds noninvasive prenatal screening using low-cost whole genome sequencing can identify mothers at risk for transmitting virus that causes hearing loss in newborns.
Read MoreThe cobas BV/CV assay aims to improve diagnostic accuracy over traditional microscopy and pH testing methods for symptomatic patients.
Read MoreThe test uses microRNA analysis and AI to diagnose endometriosis in women with chronic pelvic pain when imaging is inconclusive.
Read MoreThe molecular diagnostic system can identify complicated UTI pathogens and antibiotic resistance markers at the point-of-care in approximately 15 minutes.
Read MoreResearchers urge clinicians to integrate lipid management into prenatal care to mitigate elevated obstetric complications and cardiovascular risks.
Read MorePartnership provides mail-in semen analysis as a covered benefit for eligible members.
Read MoreThe tool uses results from the CA125 blood test along with a woman’s age to generate a personalized risk score for ovarian cancer.
Read MoreThe new noninvasive prenatal test addresses testing gaps when biological fathers are unavailable for carrier screening by analyzing fetal DNA from maternal blood samples.
Read MoreAt ADLM 2025, researchers spotlight diagnostic innovations that aim to improve gynecologic cancer detection through greater access and less invasive methods.
Read More